Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Cefalu WT, Bray GA, Home PD, et al
Report suspected adverse reactions through the MHRA Yellow Card Scheme to support ongoing medication safety monitoring
In patients currently using injectable weight loss therapies, ensure at least a 6-month period of weight stability before any surgical intervention
When you're evaluating a medication that can control type 2 diabetes and potentially reverse insulin resistance, or that can help you lose up to 20% of your body weight, enduring a temporary, mild constipation isn't a bad idea
Cagrilintide + retatrutide swaps semaglutide for retatrutide, which already hits three receptors (GLP-1, GIP, glucagon)
US$ 20.87
US$ 21.43
US$ 20.64
US$ 23.88
US$ 23.25
US$ 29.01
